Wikipedia -WSS

Wikipedia

author：explore 2025-10-01 00:46:58 - browse：569

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Humans aren't the only ones with an imagination. Rats have it too

explore

WSS

Travis Kelce and the trap of celebrity vaccine endorsements

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

The story of mRNA: From a loose idea to a tool that may help curb Covid

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Coloradans with cystic fibrosis could lose access to Trikafta

Gene therapy has helped boys walk. Can scientists keep it that way?

leisure time

Wikipedia

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

After Sarepta trial failure, Duchenne families brace for more debate

Psychedelics group wrestles with new pharma identity

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

BioMarin wins approval for gene therapy to treat hemophilia A

New guidelines on severe brain injury complicate already difficult decisions

In Memoriam: Notable people who died in 2023

Donald Trump's relentless attacks on special counsel Jack Smith

New air purifier tech could be key to improving indoor air quality

Life sciences investors close nearly $6 billion in new funds

explore

Colonoscopy at 40? Study finds a possible benefit

Medicare proceeds with plan to claw back hospital funds

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

What is microchimerism and how does it affect maternal health?

The story of mRNA: From a loose idea to a tool that may help curb Covid

Inari Medical to buy amputation prevention company LimFlow

explore

hotspot

hotspot

hotspot